• Accueil >
  • Publications >
  • Association of TP53 mutations with response and longer survival under immune checkpoint inhibitors in advanced non-small-cell lung cancer

Association of TP53 mutations with response and longer survival under immune checkpoint inhibitors in advanced non-small-cell lung cancer

1 juin 2019Lung Cancer

DOI : 10.1016/j.lungcan.2019.04.005

Auteurs

Sandra Assoun, Nathalie Theou-Anton, Marina Nguenang, Aurélie Cazes, Claire Danel, Baptiste Abbar, Johan Pluvy, Valérie Gounant, Antoine Khalil, Céline Namour, Solenn Brosseau, Gérard Zalcman